Loading...
Price History
Market Data
| Market Cap | -3.36B |
| P/E Ratio | - |
| P/B Ratio | -1.62 |
| EPS | -17.88 |
| Dividend Yield | 13.54% |
| D/E Ratio | - |
| Current Ratio | 1.32 |
| Currency | USD |
Key Financial Metrics
3.47B
Revenue
-2.24B
Net Income
-17.88
EPS (Diluted)
-
Free Cash Flow
Profitability
Gross Margin
37.0%
Operating Margin
-47.0%
Net Profit Margin
-64.6%
EBITDA
-1.32B
Returns & Efficiency
Return on Assets (ROA)
-23.1%
Return on Equity (ROE)
-108.1%
Dividend Yield
13.54%
EPS
-17.88
Financial Health
Total Assets
9.69B
Total Debt
4.07B
Debt to Equity
-
Current Ratio
1.32
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | PHILADELPHIA, PA |
| Fiscal Year | 2025 |
Peers
12.35B
P/E: 50.4
5.19B
P/E: --
5.19B
P/E: --
BALCHEM CORP
BCPC
5.17B
P/E: 36.7
CHEMOURS CO
CC
3.48B
P/E: --
OLIN CORP
OLN
3.05B
P/E: --
OLIN Corp
OLN
3.05B
P/E: --
INGEVITY CORP
NGVT
2.67B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$-3.36B
P/E Ratio (TTM)-
Price to Book-1.62
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin37.0%
Operating Margin-47.0%
Net Margin-64.6%
ROE-108.1%
ROA-23.1%
Leverage & Liquidity
Debt to Equity-
Current Ratio1.32
Total Debt$4.07B
Total Assets$9.69B
Stockholders' Equity$2.07B
Income Statement (FY 2025)
Revenue$3.47B
Gross Profit$1.28B
Operating Income$-1.63B
Net Income$-2.24B
EPS (Diluted)$-17.88
Cash Flow (FY 2025)
Free Cash Flow-
Cash & Equivalents$584.50M
Revenue Growth-18.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 2929 WALNUT STREET PHILADELPHIA, PA 19104 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 940479804 |
| Fiscal Year End | 1231 |
| Shares Outstanding | -250.34M |
| Stockholders' Equity | $2.07B |
| Cash & Equivalents | $584.50M |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-30
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-29
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | FMC CORP |
| Ticker | FMC |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | PHILADELPHIA, PA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | -3.36B |
| Revenue | 3.47B |
| Net Income | -2.24B |
| P/E Ratio | - |
| EPS | -17.88 |
| Net Margin | -64.6% |
| ROE | -108.1% |
| Dividend Yield | 13.54% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...